The impact of genetic risk on liver fibrosis in non-alcoholic fatty liver disease as assessed by magnetic resonance elastography.

Veeral AjmeraAmy LiuRicki BettencourtDebanjan DharLisa RichardsStephen Caldwell

Published in: Alimentary pharmacology & therapeutics (2021)

Knowledge of PNPLA3 and HSD17B13 genotype may assist in the non-invasive risk stratification of NAFLD with closer monitoring recommended for those with high genetic risk.

Keyphrases

liver fibrosis
magnetic resonance
genome wide
healthcare
copy number
magnetic resonance imaging
dna methylation
contrast enhanced